German study tests keto diet for myasthenia gravis symptom relief
Berlin researchers are testing keto as a complementary therapy for myasthenia gravis, with early signals on fatigue and symptom scores. The real story is a 12-week randomized trial, not a lifestyle keto trend.
In Berlin, the NeuroCure-backed “Mya-Keto-Study” is testing whether a very-high-fat, very-low-carbohydrate diet can ease symptoms of myasthenia gravis, the autoimmune neuromuscular disease that makes muscle strength fade and return unpredictably. The question is not whether keto helps with weight loss, but whether it can change metabolism enough to ease symptoms, calm inflammation, and influence immune signaling.
What researchers are testing in myasthenia gravis
Myasthenia gravis interrupts communication between nerves and muscles, which is why people can look fine one moment and then feel weakness or fatigue the next. That instability is exactly why nutrition researchers have become interested in metabolic therapies, especially in autoimmune diseases where the immune system is part of the problem.
The project is titled “Ketogenic diet as a complementary therapy for myasthenia gravis - a randomized controlled trial.” It is tied to the NCRC, the Neuroscience Clinical Research Center, and based in Berlin at Charité.
Why keto is in the frame at all
The ketogenic diet pushes the body into ketosis, a state where fat becomes the main fuel source instead of glucose. In epilepsy, that metabolic shift has a long research history, and newer work has extended the idea into autoimmune territory.
Earlier ketogenic trials in other autoimmune diseases have shown encouraging results, and the wider research wave includes a 2025 Frontiers in Nutrition review titled “Myasthenia gravis and nutrition.”
What the early MG data suggest
A 2026 study summary of a 12-week randomized study in generalized myasthenia gravis found that participants on the ketogenic diet showed clinically meaningful improvements in some symptom scores, and the diet was associated with lower serum calprotectin, a marker of inflammation. That same summary also highlighted changes tied to inflammation and immune regulation.
A 12-week trial can show whether a diet is feasible and whether symptoms move in the right direction, but it cannot settle the question of durable benefit, who is most likely to respond, or how the diet compares with standard care over months or years. The institute says larger and longer studies are needed before practical recommendations can be made.
Why the mechanism matters more than the hype
For typical keto readers, the language around this study may sound familiar, but the medical question is very different. In lifestyle keto, the focus is often appetite control, weight change, or blood sugar management. In myasthenia gravis, researchers are watching for shifts in immune signaling and inflammation that might translate into symptom relief or better disease control.
As an inflammation marker, lower serum calprotectin gives researchers a clue that the diet may be doing something biologically relevant, not just changing calories. The bigger hypothesis is that a ketogenic pattern might alter the body’s energy handling in a way that affects immune activity.
What this does not mean for ordinary keto use
This is not a green light to treat myasthenia gravis with self-directed keto, and it is not proof that keto should be added to every autoimmune plan. Myasthenia gravis is a complex chronic disease, and people living with it often rely on individualized combinations of immunotherapies, symptom management, and lifestyle adjustments.
A ketogenic diet can be difficult to sustain, and it may not be appropriate for everyone, especially when medications, swallowing issues, fatigue, and fluctuating weakness are part of the picture. In the study setting, the diet is being tested as a complementary therapy, which is a very different proposition from the casual keto advice that circulates online.
Where the research lane is heading
Keto is no longer being studied only as an epilepsy diet or a weight-loss tool; researchers are now asking whether it can affect immune-mediated disorders as well. That makes myasthenia gravis a useful test case because the disease is clearly autoimmune, clearly neuromuscular, and clearly sensitive to changes in day-to-day function.
Keto is being examined in a hospital research setting in Berlin, with randomized methods and a 12-week clock.
Every story on Keto Diet Magazine is assembled by an automated editorial system that works from verified research, official records, and credible reporting, then clears automated accuracy and moderation checks before it goes live. The standards that system follows are set and overseen by the people who run the publication. Read our full editorial policy.
Did this article answer your question?
